MJ - ETFMG Alternative Harvest ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
-0.60 (-2.31%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close26.01
Bid25.40 x 800
Ask25.60 x 800
Day's Range25.35 - 26.08
52 Week Range23.01 - 45.40
Avg. Volume451,445
Net Assets1.02B
PE Ratio (TTM)N/A
YTD Return5.21%
Beta (3Y Monthly)2.19
Expense Ratio (net)0.75%
Inception Date2015-12-03
Trade prices are not sourced from all markets
  • Ousted Canopy Growth CEO Bruce Linton says the worst is behind company's stock, buys more shares
    Yahoo Finance

    Ousted Canopy Growth CEO Bruce Linton says the worst is behind company's stock, buys more shares

    Canopy Growth's worst pain could be behind it, according to former co-CEO Bruce Linton.

  • Benzinga

    Is Weed The New Beer? 3 Key Stats Give Us An Idea

    Headset has released a new industry report with insights about cannabis-infused beverages. The firm took a deep dive into the stats of the beverage market including data from Colorado, Washington and Nevada, hitting points about infused beverages, a breakdown of what is selling by state, data on who is drinking what and more. Headset concluded the cannabis-infused beverage category meets a need that people didn’t even know they had.

  • InvestorPlace

    The MJ ETF Solves Some of the Problems of Pot Stocks — But Not All of Them

    So far in 2019, cannabis stocks have been on a roller coaster ride. Investors are wondering which marijuana companies may be better investments for the long term. If you are interested in buying into marijuana shares, you may also want to take a closer look at the ETFMG Alternative Harvest ETF (NYSEARCA:MJ). The MJ ETF is a marijuana ETF that has about $1 billion in assets under management.Source: Shutterstock Investing in the MJ ETF may enable investors to take a long-term view on a growth industry that is likely to reach tens of billions globally in a decade or two. However, investors in the cannabis sector should also remember how choppy individual stock prices that make up the MJ ETF can be. Mechanics of Investing in the MJ ETFInvestors may be able to decrease the volatility of investing in individual stocks by holding more of them, or better yet, investing in an ETF. And at InvestorPlace, my colleagues often cover how various ETFs can help investors construct a diversified portfolio.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSimilarly, MJ seeks to provide investment results that correspond to the total return performance of the Prime Alternative Harvest Index. This index tracks the performance of U.S. and global companies that are engaged exclusively in legal activities involving cannabis for medical or non-medical purposes. * 7 Great Small-Cap Stocks to Buy MJ's expense ratio is 0.75% per year or $75 annually per $10,000 invested. For many investors, the comfort in owning a basket of stocks might be worth the price.The MJ ETF also pays dividends with a yield of 2.8%. In recent months, this marijuana ETF has become one of the most popular funds among millennial investors.While the MJ ETF is still exposed to the industry risk, it may provide a good option for investors, as it is will likely be more stable than owning some of the individual stocks. Before investing in marijuana stocks, though, it is important to do your due diligence on the MJ ETF. Companies in the MJ ETFCanada is the second country in the world -- after Uruguay -- to legalize recreational marijuana at the federal level. Since then, a number of federally licensed Canadian cannabis producers have started trading on the Toronto Stock Exchange (TSE) as well as the New York Stock Exchange (NYSE).The MJ ETF currently holds 38 stocks with about 70% allocation to pot companies and growers, many of which are Canada-based and that are becoming increasingly mainstream. Several of the major stocks in the MJ ETF include Aurora Cannabis (NYSE:ACB), Cronos Group (NASDAQ:CRON), GW Pharmaceuticals (NASDAQ:GWPH), Canopy Growth (NYSE:CGC), Tilray (NASDAQ:TLRY) and Green Organic Dutchman Holdings (OTCMKTS:TGODF) It also has an allocation of tobacco stocks and fertilizer companies. The top 10 holdings represent about 60% of holdings in the MJ ETF.One fundamental point that investors need to keep in mind is that most of these cannabis producer stocks are not profitable yet. Analysts value them mostly based on the expectation of high revenue growth, which would lead to future profits. Therefore, whenever Wall Street fears the given company is failing to meet growth or expectations, that pot stock will get penalized.While MJ can avoid some of the bad performances of most marijuana stocks, it would be difficult for it to outperform several of its large holdings, such as Cronos Group, Aurora Cannabis and Canopy Growth. Nonetheless, the level of diversification helps make the MJ ETF more robust than any individual stock in the sector, limiting volatility and downside while retaining the exposure to the market's potential upside. Cannabis Industry in Canada is Still in the Early InningsThe lure of higher-than-average returns may be tempting for many pot stock investors. After all, early investors in many of these stocks have been rewarded handsomely.But as the cannabis industry in Canada matures, will the fundamental forces allow for high double-digit returns any more?The recent earnings reports from Canada-based pot stocks are important in gauging the health of the industry. At present, not everyone is convinced that Canadian recreational pot sales will remain strong. Many investors are concerned that the initial hype surrounding the industry could be decreasing.Since legalization in October 2018, Canadian sales numbers have been muted without any signs of increasing. In 2019, the total cannabis market in Canada, including both legal and illegal recreational and medical sales, is expected to be around $7.2 billion CAD. About half of it is likely to come from legal sales. The Canadian market may also be running the risk of being oversupplied. * 15 Growth Stocks to Buy for the Long Haul Is all this capacity truly needed, given that export volumes are not expected to meaningfully offset oversupply, either? If these marijuana companies harvest more than what they sell, there will be higher inventory balances. And simple economics tells us that a supply glut would eventually drive down the price of marijuana along with the margins of these companies. The developments in Canada over the past year has been reflected in the stock price of most of these Canada-based companies, moving investor sentiment from euphoria to greed to fear.Marijuana is illegal in the U.S. at the federal level. However, at the state level, its legal status depends on the laws of the individual state. In other words, the legalized marijuana industry is still in its infancy, even in Canada, and it is almost non-existent globally. None of the Canadian marijuana stocks have so far done any business in these pot-friendly U.S. states, as the listing requirements at the NYSE or NASDAQ as well as at the Toronto Stock Exchange bar companies from engaging in commercial activities in countries where they would be breaking the U.S. federal law. Where Is the MJ ETF Price Now?In the past two years, marijuana stocks have been choppy and highly speculative. Their valuations can and do change suddenly and drastically, both as a result of event-driven company news or developments in the industry.So far in 2019, with the exception of January, when many stocks did well, investors have witnessed considerable bearish activity in the industry. For most cannabis stocks as well as the MJ ETF, it hasn't exactly been such a "hot" summer. And the value of this particular marijuana ETF reflects this volatility. Year-to-date, the MJ ETF is up 5%. After seeing an intraday low of $23.3 on Dec. 24, 2018, it has rallied to a high of $39.25 on March 19. Its 52-week high remains at $45.4, reached on Sep. 19, 2018. Currently it is hovering around $26.Those investors who pay attention to technical charts should note that due to the decline in price since April, MJ ETF has a not-so-pretty technical picture. In the long run, MJ needs to build a base again before a long-term sustained leg up can occur.From a price and time cycle perspective, the high reached on March 19, 2019, which came six months after the 52-week high of Sept. 19, 2018, is likely to be the highest price to be seen in the near-term. And MJ price may see a new 52-week low in Sept. 2019, possibly around $22.5, about a year after the current 52-week high of $45.4. Within the next month, I expect MJ to mostly range-trade between $27.5 and $25.However, in case of a broader market selloff, similar to the one we have witnessed in the last quarter of 2018, the fund may easily go toward the low-$20's level. The Bottom Line on the MJ ETFFor most of the year, I have been bearish on most marijuana stocks. The hype that has led to high valuation levels, their mostly poor earnings and the dependency on the recreational aspects of cannabis make them risky and volatile investments.Given the risk involved with investing in cannabis, no ETF holding pot stocks is going to be completely safe in being able to avoid losses, but MJ offers investors some safety due to diversification.Now that the sentiment has swung negative, contrarian investors may find value in the MJ ETF. However, investors still need to follow developments in the industry closely to evaluate the appropriateness for marijuana stocks for their portfolio.It is important to note that unless legalization at the federal level in the U.S. happens, cannabis market is, for the most part, limited to the growth in Canada. And a limited Canadian market is not likely to help most of these pot stocks become profitable on an operating basis. This fact makes marijuana stock valuations even more difficult to justify. * 10 Cheap Dividend Stocks to Load Up On Therefore, MJ investors should be ready for daily price fluctuations as well as high volatility around the earnings release dates of the marijuana stocks that mostly make up the ETF. Most of these Canada-based weed companies also have high operating expenses. And the red ink at the bottom of their income statements, quarter after quarter, is becoming a worry for shareholders. If the international cannabis market does not grow as expected, then MJ ETF's price could also experience selling pressure.As of this writing, Tezcan Gecgil did not hold a position in any of the aforementioned securities.The post The MJ ETF Solves Some of the Problems of Pot Stocks -- But Not All of Them appeared first on InvestorPlace.

  • Benzinga

    Defying The Odds With A Dream, Some Weed, And A Ton Of Determination: The Inside Scoop On Frank Shamrock

    Ortiz had three consecutive wins before the fight, with one being a 0:16 submission against Jeremy Screeton.  He was also noticeably bigger than Shamrock, and had more fights under his belt. Despite landing some pretty heavy blows in the first three rounds, Ortiz did begin to tire by the fourth round, and that’s when Shamrock dropped a calamitous elbow that landed with what I can only imagine being similar to the force of a Nimitz class aircraft carrier. You see, these guys aren’t street thugs.  They’re not hot-headed bar fighters looking to blow off some steam.  These guys are some of the most gifted  and well-disciplined athletes on the planet.  The sacrifice and dedication it takes to get to this level is almost inhuman.  But it’s also the kind of sacrifice and dedication that can make these guys successful in anything they choose to do.  And there is no better example of this than Frank Shamrock.

  • Spooked About Recessionary Fears? Bet on Sin Stocks & ETFs

    Spooked About Recessionary Fears? Bet on Sin Stocks & ETFs

    These sin stocks and ETFs may prove to be recession-proof.

  • ETF Winners & Losers of Last Week

    ETF Winners & Losers of Last Week

    We have highlighted last week's best and worst performing ETFs.

  • Benzinga

    A Couple Data Points On The Main Drivers Of Cannabis Stock Investing

    A recent user survey conducted by Investing.com revealed that state legislation regarding marijuana legalization is driving investor interest in pot stocks. Looking into 8 million users across the U.S., they found that investors in states that had legalized marijuana showed the a much greater interest in investing in the substance, with Maine, Massachusetts, Michigan, Alaska and California ranking as the top five states for investor interest. Investing.com's partner on the survey, SEMrush also found a drastic increase in Google searches for pot socks in each of the aforementioned states following legalization, in excess of 100% in most cases.

  • Benzinga

    Global Alliance For Cannabis Commerce Launches In Los Angeles

    Article originally posted on LA Weekly, provided to Benzinga Cannabis by the author. A new national advocacy organization has launched in Los Angeles to advocate and educate lawmakers on the path towards federal cannabis legalization. Mr. Jason Beck, a longtime Angeleno who was born with cerebral palsy and an early medical cannabis patient, spearheaded the creation of the new organization.  The Global Alliance for Cannabis Commerce (GACC) will focus on legislation including, cultivation, manufacture, distribution, public safety, and taxation of medical and adult-use cannabis.

  • Benzinga

    Michigan Policymakers Discuss The Future At Cannabis Capital Conference

    In November 2018, Michigan’s government helped push through voter efforts to legalize recreational marijuana use and distribution within specific legal parameters. The legislative change is only a small checkpoint in a longstanding timeline of events for the cannabis industry. Due to the heavy role that the state’s government will continue to play as it relates to the modification of marijuana laws, a few individuals in the policy space came together Thursday at the Benzinga Cannabis Capital Conference to discuss the past, present and future of cannabis legality.

  • Benzinga

    Big Opportunities: Michigan Cannabis Market 'Could Easily Eclipse $2B'

    Since Michigan voters approved and created the Michigan Regulation and Taxation of Marijuana Act (MRTMA) in late 2018, which legalized recreational usage of marijuana within certain parameters, the state has become a hub of cannabis startups and investors. Both agree Michigan represents an enormous opportunity for companies and investors.

  • Cannabis Stocks’ Volatility Spike Tied to ETF’s Mega Trades

    Cannabis Stocks’ Volatility Spike Tied to ETF’s Mega Trades

    The speculative nature of the cannabis industry has led to some wild swings in pot stocks, but an ETF's big trades are also adding to the volatility.

  • Canopy Growth shares tank 15% after company reports disappointing quarter
    Yahoo Finance

    Canopy Growth shares tank 15% after company reports disappointing quarter

    Canopy Growth shares fell 12% in after-hours trading following a fiscal first-quarter earnings report that showed a wider than expected net loss.

  • Benzinga

    Is Oregon Set To Legalize Magic Mushrooms?

    Oregon is one step closer to voting in November 2020 to legalize medicinal psilocybin mushrooms for adults in the state. While current laws prohibit the use and possession of psilocybin, a hallucinogenic compound from "magic mushrooms," activists in the state are championing the Oregon Psilocybin Services Act. Under the proposed measure, the Oregon Health Authority (OHA) would establish a regulatory program allowing for the production, processing, delivery, possession and administration of psilocybin.

  • Benzinga

    7 Cannabis Business Tips From Leading Marijuana Retailers

    By the end of 2019, retail sales are expected to top $12 billion - an increase of 35%, according to Marijuana Business. It’s one thing to offer the best bud, but in today’s retail landscape where new brands and product categories are emerging, it’s important to stay current with shifting trends and tastes of consumers. As the cannabis industry’s wholesale marketplace, LeafLink works with thousands of retailers to simplify their purchasing processes.

  • Tilray reports wider-than-expected 2Q losses, higher sales
    Yahoo Finance

    Tilray reports wider-than-expected 2Q losses, higher sales

    Canadian cannabis company Tilray reported second-quarter 2019 results after market close Tuesday.

  • Benzinga

    The Complicated Business Of Advertising And Marketing In Cannabis

    By Aaron Silverman, President of MediaJel . New companies tend to cultivate similarly. Build a winning team and culture. Plan and establish your vision of success – but maintain flexibility. Structure ...

  • ETF.com

    Why Cannabis ETF Spreads Are So High

    We look at what does—and doesn't—influence liquidity in marijuana funds.

  • Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

    Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

    CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.

  • ETFs in Focus as Consolidation Drives Marijuana Industry

    ETFs in Focus as Consolidation Drives Marijuana Industry

    Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.

  • Aurora Cannabis Pulls Ahead of Peers After Sharing a Peek at Q4 Results

    Aurora Cannabis Pulls Ahead of Peers After Sharing a Peek at Q4 Results

    Cannabis stocks keep getting hammered in what has been one of the worst sell-offs for the sector in the past two years. From speculative upstarts through to the industry leaders, everyone's shares have been wilting. If anything is going to change the mood, however, it could be positive earnings. That seems to be the case with Aurora Cannabis (NYSE:ACB) whose shares popped more than 10% after it gave a sneak peek at its fourth quarter results on Aug. 6. ACB stock, overall, is up 5% this month, compared to a 2.1% gain in the pot-stock exchange-traded fund ETFMG Alternative Harvest ETF (NYSEArca:MJ).The Aurora Cannabis preview of results due out on Sept. 15 finally gave investors a sign that at least one marijuana company is building a more sustainable business. In a world where rivals like Hexo (NYSE:HEXO) and Canopy Growth (NYSE:CGC) keep growing production capacity far in excess of demand while losses mount, Aurora may be set to buck the tide.InvestorPlace - Stock Market News, Stock Advice & Trading Tips On Track to Profitability (Sort of)In its preliminary Q4 results, Aurora surprised the market. It confirmed that production is strong, near the high end of its range. That's not so important though, as there isn't demand for as much marijuana as Aurora is producing. What is important, however, is that Aurora generated more revenue than analysts had expected. This speaks to some combination of either higher profit margins than anticipated, or more sales volume. Either outcome, of course, is a plus for ACB stock. * 10 Cyclical Stocks to Buy (or Sell) Now All this adds up to Aurora being on pace to generate positive adjusted EBITDA for the fourth quarter, which is one type of profitability. But make no mistake, this is still not equal to net income. EBITDA is earnings before interest, taxes, depreciation, and amortization. It's a big positive step for a marijuana company to achieve positive EBITDA. Most aren't even close to it yet. But it's another hurdle to get to profitability.To be sure, Aurora does have plenty of those other costs. It has interest, for example, because it has quietly accumulated a rather sizable debt load. This has led analysts such as Christopher Carey of Bank of America to criticize ACB stock due to its balance sheet and cash burn. Aurora has also pumped out tons of new ACB stock shares to raise money. Its share count is up from around 400 million at the start of 2018 to a billion now. That's some serious dilution. It's a good sign that Aurora is reaching positive EBITDA, but it needs to get to positive net income as well sooner or later, or the share dilution will only get worse. Italy Deal: A Plus, and a MinusRecently, Aurora announced a deal to be the only official supplier to Agenzia Industrie Difesa, an agency of the Italian government. This agency will distribute medical marijuana around the country. Aurora anticipates finalizing the deal next month. Notably, Aurora competed against four other bidders for the contract, but was the only one that could meet all of the government's requirements. * 5 Cheap Stocks to Buy Now That the Fed Cut Rates On the one hand, this deal is a clear positive for Aurora. It's no secret that the Canadian marijuana market is sagging due to massive oversupply. Marijuana producers are all trying to become the biggest and most well-known as fast as possible. But the demand picture hasn't nearly kept up with supply. Legalization didn't unleash unlimited consumer interest. Click to EnlargeSo Aurora has validated its business model of focusing on the global market outside of just the U.S. and Canada. On the other hand, the Italy deal may be way too small to matter. Aurora's contract authorizes it to distribute a minimum of 400 kilos of medical marijuana over the next two years. That's a minimum, so it could be a lot more. But to put 400 kilos in two years in perspective, however, Aurora is now producing nearly 30,000 kilos of product per quarter. It will take a ton of 400 kilo-type deals to mop up that sort of supply. ACB Stock VerdictInitiatives such as the contract in Italy should help differentiate Aurora from its competition. So far, however, Aurora has not achieved that much with overseas dealings. It's only managed $4 CAD million ($3.03 million) or so in quarterly revenues from outside of Canada so far, which puts international sales in the single digit percentage range of the company's entire revenues.At least for now, Aurora remains highly dependent on Canadian sales. And there simply aren't enough consumers to achieve the ambitious growth goals that Aurora and its peers are pursuing within the Canadian market. If Canadian consumption doesn't pick up quickly, other markets need to come online. Otherwise, the sector will keep trading lower.ACB stock is positioned better than many of its peers, as the company's preliminary Q4 numbers demonstrate. But it's hard to get especially excited about any of these Canada-based marijuana stocks until the supply glut starts to reverse itself. Aurora looks better than many of its peers, but the sector is in trouble.At the time of this writing, Ian Bezek held no positions in any of the aforementioned securities. You can reach him on Twitter at @irbezek. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 8 Dividend Aristocrat Stocks to Buy Now No Matter What * 7 Stocks to Buy to Ride the Vegan Wave * 4 Safe Stocks to Buy Amid Trade War Turbulence The post Aurora Cannabis Pulls Ahead of Peers After Sharing a Peek at Q4 Results appeared first on InvestorPlace.

  • Benzinga

    Want to Get a Medical Marijuana Card? Here's What You Need to Know

    While cannabis remains illegal under federal law, state-approved medical marijuana programs continue to sprout like weeds across the United States – and in other parts of the world, too. The key that allows you to reap the benefits of the cannabis plant is a state-specific identification card called the medical marijuana card (also known as a cannabis card or weed card). As of July 2019, the use of cannabis for medicinal purposes has been legalized in 33 states, along with Washington, D.C. As the first state to legalize medical marijuana, California drew the initial blueprint with the 1996 passage of the Medical Use of Marijuana Initiative.

  • Benzinga

    Has The Moment For Cannabis Banking Reform Finally Arrived?

    The multi-billion-dollar cannabis industry in the U.S. is largely restricted to cash-only transactions. Will Congress or technology companies be the first to provide a solution for this growing industry?

  • How Much Of True Leaf Brands Inc. (CNSX:MJ) Do Insiders Own?
    Simply Wall St.

    How Much Of True Leaf Brands Inc. (CNSX:MJ) Do Insiders Own?

    Every investor in True Leaf Brands Inc. (CNSX:MJ) should be aware of the most powerful shareholder groups. Large...

  • 2 Marijuana Stocks to Buy Heading into Q2 Earnings and Beyond

    2 Marijuana Stocks to Buy Heading into Q2 Earnings and Beyond

    The marijuana industry is projected to grow at an annual rate of about 17% until it reaches $55.8 billion a year in 2025. The cannabis market has roughly tracked the S&P 500' s expansion in 2019 so far.

  • Benzinga

    Why You Should Attend The Cannabis Capital Conference In Detroit

    After three incredibly successful versions of the Cannabis Capital Conference, the Benzinga events team is bringing the next iteration to our hometown of Detroit. The Cannabis Capital Conference takes place Aug. 15 at the Westin Book Cadillac in downtown Detroit. Who Comes To The Conference? The most important part of Benzinga events remains the strong focus on connecting well-vetted companies with a high tier of institutional and accredited investors.